Matinas BioPharma Holdings, Inc. (MTNB)
0.8557
-0.07
(-7.69%)
USD |
NYAM |
Nov 17, 16:00
0.8134
-0.04
(-4.94%)
After-Hours: 20:00
Matinas BioPharma Holdings Price : 0.8557 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 0.9408 | 0.9408 | 0.8133 | 0.8557 | 50105.00 |
| Nov 16, 2026 | 0.9349 | 1.00 | 0.885 | 0.927 | 58332.00 |
| Nov 13, 2026 | 0.90 | 0.90 | 0.87 | 0.90 | 43214.00 |
| Nov 12, 2026 | 0.9261 | 0.9299 | 0.845 | 0.9184 | 38630.00 |
| Nov 11, 2026 | 1.23 | 1.23 | 0.8071 | 0.93 | 188327.0 |
| Nov 10, 2026 | 1.25 | 1.26 | 1.187 | 1.23 | 6046.00 |
| Nov 09, 2026 | 1.19 | 1.26 | 1.160 | 1.24 | 24257.00 |
| Nov 06, 2026 | 1.22 | 1.25 | 1.120 | 1.19 | 35662.00 |
| Nov 05, 2026 | 1.19 | 1.29 | 1.107 | 1.16 | 58787.00 |
| Nov 04, 2026 | 1.17 | 1.20 | 1.075 | 1.19 | 28775.00 |
| Nov 03, 2026 | 1.29 | 1.45 | 1.00 | 1.14 | 110992.0 |
| Nov 02, 2026 | 1.49 | 1.54 | 0.9662 | 1.29 | 224162.0 |
| Oct 30, 2026 | 1.87 | 1.91 | 1.505 | 1.51 | 83000.00 |
| Oct 29, 2026 | 1.88 | 1.90 | 1.88 | 1.90 | 2687.00 |
| Oct 28, 2026 | 1.76 | 1.93 | 1.76 | 1.91 | 9136.00 |
| Oct 27, 2026 | 1.75 | 1.90 | 1.74 | 1.83 | 27802.00 |
| Oct 26, 2026 | 1.59 | 1.75 | 1.58 | 1.66 | 49734.00 |
| Oct 23, 2026 | 1.71 | 1.78 | 1.69 | 1.701 | 11289.00 |
| Oct 22, 2026 | 1.53 | 1.80 | 1.52 | 1.71 | 48427.00 |
| Oct 21, 2026 | 1.69 | 1.69 | 1.469 | 1.52 | 19906.00 |
| Oct 20, 2026 | 1.66 | 1.72 | 1.51 | 1.70 | 48558.00 |
| Oct 19, 2026 | 2.37 | 2.37 | 1.50 | 1.66 | 273464.0 |
| Oct 16, 2026 | 2.48 | 2.50 | 2.36 | 2.37 | 27337.00 |
| Oct 15, 2026 | 2.44 | 2.54 | 2.42 | 2.42 | 20951.00 |
| Oct 14, 2026 | 2.51 | 2.55 | 2.452 | 2.48 | 19794.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.84 |
| Alnylam Pharmaceuticals, Inc. | 149.48 |
| Anika Therapeutics, Inc. | 13.62 |
| Savara, Inc. | 4.735 |
| Arrowhead Pharmaceuticals, Inc. | 43.12 |
Price Related Metrics
| Price to Book Value | 0.3216 |
| Earnings Yield | -2.50K% |
| Market Cap | 0.3655M |